Product Description: NY-ESO-1 (157–165) peptide is a peptide fragment from NY-ESO-1 protein. NY-ESO-1 (157–165) peptide can activate the immune system, especially for HLA-A2 positive individuals, it can be recognized by CD8+ T cells, thus triggering an immune response. NY-ESO-1 (157–165) peptide is expressed in a variety of tumors and can be used as a target for tumor immunotherapy. NY-ESO-1 (157–165) peptide can be used in the study of cancer immunotherapy[1].
Applications: Cancer-programmed cell death
Formula: C49H79N11O13S2
References: [1]Davis I D, et al. Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans[J]. Proceedings of the National Academy of Sciences, 2004, 101(29): 10697-10702.
CAS Number: 202815-17-6
Molecular Weight: 1094.35
Research Area: Cancer; Others
Target: Others